Emerging role of novel therapies in Hodgkin lymphoma: proceed with caution

著者: Bartlett, Nancy L.
出版年 Hematology Am Soc Hematol Educ Program (2017)

Approaches to aggressive B-cell lymphomas in less fit patients

著者: Bartlett, Nancy L.
出版年 Hematology Am Soc Hematol Educ Program (2020)

Management of relapsed/refractory classical Hodgkin lymphoma in transplant-ineligible patients

著者: Mehta-Shah, Neha, Bartlett, Nancy L.
出版年 Blood (2018)

(18)F-FDG PET/CT for Early Response Assessment in Diffuse Large B-Cell Lymphoma: Poor Predictive Value of International Harmonization Project Interpretation

著者: Cashen, Amanda F., Dehdashti, Farrokh, Luo, Jingqin, Homb, Andrew, Siegel, Barry A., Bartlett, Nancy L.
出版事項 2011

Phase II Study of 9-aminocamptothecin in Previously Treated Lymphomas: Results of Cancer and Leukemia Group B 9551

著者: Bartlett, Nancy L., Johnson, Jeffrey L., Wagner-Johnston, Nina, Ratain, Mark J., Peterson, Bruce A.
出版年 Cancer Chemother Pharmacol (2008)

High Incidence of Methotrexate Associated Renal Toxicity in Patients with Lymphoma: A Retrospective Analysis

著者: May, Jori, Carson, Kenneth R., Butler, Sara, Liu, Weijian, Bartlett, Nancy L., Wagner-Johnston, Nina D.
出版事項 2013

The anti-CD80 primatized monoclonal antibody, galiximab, is well-tolerated but has limited activity in relapsed Hodgkin lymphoma: Cancer and Leukemia Group B 50602 (Alliance)

著者: Smith, Sonali M., Schöder, Heiko, Johnson, Jeffrey L., Jung, Sin-Ho, Bartlett, Nancy L., Cheson, Bruce D.
出版年 Leuk Lymphoma (2013)

Brentuximab Vedotin in Transplant-Naïve Patients with Relapsed or Refractory Hodgkin Lymphoma: Analysis of Two Phase I Studies

著者: Forero-Torres, Andres, Fanale, Michelle, Advani, Ranjana, Bartlett, Nancy L., Rosenblatt, Joseph D., Kennedy, Dana A., Younes, Anas
出版事項 2012

Rituximab is associated with improved survival in Burkitt lymphoma: a retrospective analysis from two US academic medical centers

著者: Wildes, Tanya M., Farrington, Laura, Yeung, Cecilia, Harrington, Alexandra M., Foyil, Kelley V., Liu, Jingxia, Kreisel, Friederike, Bartlett, Nancy L., Fenske, Timothy S.
出版事項 2014

Patient-reported outcomes of brentuximab vedotin in Hodgkin lymphoma and anaplastic large-cell lymphoma

著者: Chen, Robert, Allibone, Suzanne, Bartlett, Nancy L, Brice, Pauline, Chen, Andy, Pose, Katrina, Rich, Lynn, Bonthapally, Vijay, Garfin, Phillip M, Fanale, Michelle
出版年 Onco Targets Ther (2016)

Outcomes of transformed follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS)

著者: Wagner-Johnston, Nina D., Link, Brian K., Byrtek, Michelle, Dawson, Keith L., Hainsworth, John, Flowers, Christopher R., Friedberg, Jonathan W., Bartlett, Nancy L.
出版年 Blood (2015)

Therapy with bortezomib plus lenalidomide for relapsed/refractory mantle cell lymphoma: Final results of a phase II trial (CALGB 50501)

著者: Morrison, Vicki A., Jung, Sin-Ho, Johnson, Jeffrey, LaCasce, Ann, Blum, Kristie A., Bartlett, Nancy L., Pitcher, Brandelyn N., Cheson, Bruce D.
出版年 Leuk Lymphoma (2014)

Increased Body Mass Index Is Associated With Improved Survival in United States Veterans With Diffuse Large B-Cell Lymphoma

著者: Carson, Kenneth R., Bartlett, Nancy L., McDonald, Jay R., Luo, Suhong, Zeringue, Angelique, Liu, Jingxia, Fu, Qiang, Chang, Su-Hsin, Colditz, Graham A.
出版事項 2012

Randomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance)

著者: Leonard, John P., Jung, Sin-Ho, Johnson, Jeffrey, Pitcher, Brandelyn N., Bartlett, Nancy L., Blum, Kristie A., Czuczman, Myron, Giguere, Jeffrey K., Cheson, Bruce D.
出版年 J Clin Oncol (2015)

Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin

著者: Horwitz, Steven M., Advani, Ranjana H., Bartlett, Nancy L., Jacobsen, Eric D., Sharman, Jeff P., O’Connor, Owen A., Siddiqi, Tanya, Kennedy, Dana A., Oki, Yasuhiro
出版年 Blood (2014)

A pilot study of lenalidomide maintenance therapy after autologous transplantation in relapsed or refractory classical Hodgkin lymphoma

著者: Shea, Lauren, Watkins, Marcus P., Wan, Fei, Cashen, Amanda, Wagner-Johnston, Nina, Jacoby, Meagan, Abboud, Camille, Dipersio, John, Hurd, David, Jaglowski, Samantha, Bartlett, Nancy L., Fehniger, Todd
出版年 Biol Blood Marrow Transplant (2020)

Assessment of Cellular Proliferation in Tumors by PET Using (18)F-ISO-1

著者: Dehdashti, Farrokh, Laforest, Richard, Gao, Feng, Shoghi, Kooresh I., Aft, Rebecca L., Nussenbaum, Brian, Kreisel, Friederike H., Bartlett, Nancy L., Cashen, Amanda, Wagner-Johnson, Nina, Mach, Robert H.
出版事項 2013

Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance)

著者: Rosenbaum, Cara A., Jung, Sin-Ho, Pitcher, Brandelyn, Bartlett, Nancy L., Smith, Sonali M., Hsi, Eric, Wagner-Johnston, Nina, Thomas, Sachdev P., Leonard, John P., Cheson, Bruce D.
出版年 Br J Haematol (2019)

Bendamustine Is Effective Therapy in Patients With Rituximab-Refractory, Indolent B-cell Non-Hodgkin Lymphoma: Results From a Multicenter Study

著者: Kahl, Brad S., Bartlett, Nancy L., Leonard, John P., Chen, Ling, Ganjoo, Kristen, Williams, Michael E., Czuczman, Myron S., Robinson, K. Sue, Joyce, Robin, van der Jagt, Richard H., Cheson, Bruce D.
出版事項 2010

Interim FDG PET Imaging in Stage I/II Non-Bulky Hodgkin Lymphoma: Would using combined PET and CT criteria better predict response than each test alone?

著者: Kostakoglu, Lale, Schöder, Heiko, Johnson, Jeffrey L., Hall, Nathan C., Schwartz, Lawrence H., Straus, David J., LaCasce, Ann S., Jung, Sin-Ho, Bartlett, Nancy L., Canellos, George P., Cheson, Bruce D.
出版年 Leuk Lymphoma (2012)